Strides Pharma Science submits unaudited financial results

02 Aug 2023 Evaluate
Strides Pharma Science has informed that it enclosed the Un-audited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2023, as approved by the Board of Directors of the Company at their meeting held today, August 2, 2023. The Board Meeting commenced at 10:30 hrs IST and concluded at 11:45 hrs IST.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

796.20 -68.60 (-7.93%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×